We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-4.69%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
-$972M
Cap. Flow
+$106M
Cap. Flow %
0.72%
Top 10 Hldgs %
23.63%
Holding
875
New
75
Increased
357
Reduced
296
Closed
67

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$90.2M
2
MRK icon
Merck
MRK
+$70M
3
ADBE icon
Adobe
ADBE
+$55.1M
4
BKNG icon
Booking.com
BKNG
+$34.5M
5
NOW icon
ServiceNow
NOW
+$30.3M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$51.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$40.4M
3
CRM icon
Salesforce
CRM
+$36.7M
4
INFO
IHS Markit Ltd. Common Shares
INFO
+$36.4M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$30.1M

Sector Composition

Rank Sector Weight
1 Healthcare 29.35%
2 Technology 26.36%
3 Financials 8.78%
4 Communication Services 7.85%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMUS icon
251
T-Mobile US
TMUS
$195B
$10.3M 0.07%
80,172
+48,873
+156% +$5.82M
DG icon
252
Dollar General
DG
$28.4B
$10.2M 0.07%
45,954
-384
-0.8% -$81.6K
PTCT icon
253
PTC Therapeutics
PTCT
$6.18B
$10.2M 0.07%
273,374
– –
KEY icon
254
KeyCorp
KEY
$23.8B
$10.1M 0.07%
450,946
+68,478
+18% +$1.7M
ANET icon
255
Arista Networks
ANET
$199B
$10M 0.07%
287,828
+244,588
+566% +$7.73M
ICE icon
256
Intercontinental Exchange
ICE
$87.2B
$9.99M 0.07%
75,611
+5,611
+8% +$725K
KPTI icon
257
Karyopharm Therapeutics
KPTI
$155M
$9.84M 0.07%
89,002
+30,491
+52% +$3.8M
MTOR
258
DELISTED
MERITOR, Inc.
MTOR
$9.76M 0.07%
+274,374
New +$8.11M
ZTS icon
259
Zoetis
ZTS
$32.7B
$9.73M 0.07%
51,581
+1,914
+4% +$378K
PLAN
260
DELISTED
Anaplan, Inc.
PLAN
$9.68M 0.07%
+148,798
New +$7.25M
CLDX icon
261
Celldex Therapeutics
CLDX
$2.94B
$9.45M 0.06%
277,481
-109,740
-28% -$3.51M
CTXS
262
DELISTED
Citrix Systems Inc
CTXS
$9.44M 0.06%
93,587
+89,488
+2,183% +$9.04M
FATE icon
263
Fate Therapeutics
FATE
$275M
$9.44M 0.06%
243,440
-7,297
-3% -$283K
TEN
264
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$9.43M 0.06%
+514,978
New +$7.39M
GH icon
265
Guardant Health
GH
$19.1B
$9.25M 0.06%
139,581
-7,708
-5% -$527K
SWTX
266
DELISTED
SpringWorks Therapeutics
SWTX
$9.15M 0.06%
162,109
-10,447
-6% -$598K
IR icon
267
Ingersoll Rand
IR
$33.1B
$9.05M 0.06%
179,785
+150,607
+516% +$8.07M
CERE
268
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$8.81M 0.06%
251,618
+146,019
+138% +$4.26M
M icon
269
Macy's
M
$6.51B
$8.77M 0.06%
359,884
+144,820
+67% +$3.71M
DLO icon
270
dLocal
DLO
$4.29B
$8.72M 0.06%
279,000
+48,400
+21% +$1.46M
NTES icon
271
NetEase
NTES
$83B
– –
0
– –
MAA icon
272
Mid-America Apartment Communities
MAA
$16B
$8.44M 0.06%
40,274
+1,795
+5% +$376K
CCMP
273
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$8.42M 0.06%
45,402
+29,434
+184% +$5.43M
REPL icon
274
Replimune Group
REPL
$455M
$8.36M 0.06%
492,504
-27,008
-5% -$510K
ENTA icon
275
Enanta Pharmaceuticals
ENTA
$362M
$8.15M 0.06%
114,507
-46,851
-29% -$3.05M
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2022 Portfolio in Review

As of Q1 2022, Candriam SCA held 875 positions worth $14.7B, down 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2022 filing shows 75 new, 357 increased, 296 reduced and 67 closed positions. Its largest new stake was Ecopetrol: 1,389,000 shares worth $25.8M. The largest sale was Amgen, an estimated $51.3M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2022 buy was Ecopetrol: 1,389,000 shares worth $25.8M.
  • Candriam SCA added most to Walt Disney in Q1 2022, an estimated $90.2M increase.
  • Candriam SCA's biggest Q1 2022 reduction was Amgen, cutting an estimated $51.3M.
  • Candriam SCA fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $36.4M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.7B portfolio in Q1 2022.
  • Candriam SCA opened 75 new positions and closed 67 in Q1 2022.
  • Candriam SCA's portfolio value fell 6.2% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.